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Summary. The present work was carried out to evaluate the kinetic parameters of glucagon in growing rats divided into three groups : T, H and E. Group T (Control group) was fed a control diet (crude protein : 11.8 %). Groups H and E received a high protein diet (crude protein : 19 %) distributed in either equal (Group H) or restricted amounts (Group E) with respect to the control. Thus, the main characteristic of Group H was the high level of protein intake (+ 68 %) when Group E rats underwent a moderate increase in protein intake but a striking caloric deprivation (-25 %) . In all cases, the animals were fed a meal every 4 hours.
The kinetic parameters of glucagon metabolism were estimated from the plasma disappearance curves of 125 1-glucagon for five minutes following a pulse injection of purified ' z5 1-glucagon (1 A Ci, about 3.8 ng/100 g BW). Plasma ' 25 1_glucagon was measured after gel filtration of plasma on Biogel P-10. Tissue radioactivity (mainly liver and kidneys) was recorded seven minutes after ' z5 1-glucagon injection.
The results showed that the plasma ' z5 1-glucagon level was higher in Group H than in the other groups 1 min after the injection. At all other times (2, 3.5 and 5 min) it was similar in all groups. ' z5 1-glucagon was rapidly cleared from plasma and rapidly taken up by the liver and kidneys. In the 3 experimental groups, mean half-life and metabolic clearance rate were estimated to be 2 min and 6 ml/min/100 g BW, respectively. Excess protein intake resulted in a reduction in the apparent initial distribution volume of ' z5 1-glucagon without modifying significantly its turn-over rate and metabolic clearance rate. Kidneys and liver (6 % BW) accounted for about 20 % of the ' z5 1-glucagon uptake by tissues 7 min after injection. Group H kidneys and liver were more labelled than in other groups. These results suggest that increased protein intake (without further caloric deprivation) can induce some changes in glucagon metabolism which could partially contribute to the increase in glucagonemia usually observed in animals fed high protein diets.
Introduction.
An increased dietary protein intake in growing animals results in an increase of body protein content (Henry and Rérat, 1965) . On the other hand, a large excess of protein intake increases amino-acid extraction by the liver and gluconeogenesis (Peret et al., 1981 ; Fafournoux, Rémésy and Demigné, 1982) . These metabolic adaptable responses could be correlated with an increment of glucagon effects on liver since this hormone enhances amino-acid transport ang gluconeogenesis in liver (Le Cam and Freychet, 1976 ; Fehlmann, Le Cam and Freychet, 1979 ; Fehlmann et al., 1981 ; Morin, Fehlmann and Freychet 1982 ; Ayuso-Parilla, 1975, 1976) . High levels of plasma glucagon have generally been associated with high protein diets (Tiedgen and Seitz, 1980 ; Eisenstein and Strack, 1978 ; Eisenstein et al., 1979 ; Peret et al., 19811. Changes in plasma hormone concentration may result from a stimulation of pancreatic a cells by amino acids (Dencker et al., 1975 ; Jarrousse et al., 1980) (Genuth, 1972 ; Sherwin et al., 1974 (fig. 3) ; the mean regression lines were highly significant (P < 0.0011. Thus, the kinetic parameters of !251-glucagon metabolism could be reasonably calculated, assuming that !z51-glucagon was distributed in one homogeneous compartment. However this must be accepted with caution (see Discussion).
The apparent turn-over rate and half-life of !z51-glucagon were constant whatever the nutritional conditions of the animals ( fig. 4) Hoorn-Hickman, 1978 ; Brockman, 1980 ; Jaspan et al., 1981 ; Hayashi, 1982) , but the apparent half-life and metabolic clearance rate values were respectively smaller (2 min vs 3-5 min) and higher (6 ml/min/100 g BW vs 0.5-1.5 ml/min/100 g BW) than those obtained in most works referred to. This discrepancy may be partially explained by the use of a pulse injection technique instead of a constant infusion technique.
Indeed, during the short period after !251-glucagon injection, the disappearance of !251_glucagon from the circulation involved both tissue uptake and diffusion into the blood and some areas of the extracellular space. Furthermore, all quoted works were performed in species other than rats, using unlabelled hormone. The amount of !251-glucagon injected (i.e. about 3.8 ng/100 g BW) might not have interfered since a large increase in glucagonemia after the infusion of native hormone did not modify glucagon metabolism Alford, Bloom and Nabarro, 1976) .
Seven min after !z51-glucagon injection, about 20 % of the total injected radioactivity was present in liver and kidneys which represent only 6 % of the whole body mass (the radioactivity present in other tissues was always less than 1 % per g of tissue). This suggests that !251-glucagon was greatly taken up by the liver and kidneys and confirms that these organs are major sites of glucagon metabolism (Lefebvre, Luyckx and Nizet, 1974 ; Lefebvre and Luyckx, 1976 ; Sherwin et al., 1976 ; Jaspan et al., 1977, 19811 . The high level of radioactivity in kidneys when compared to liver agrees with further studies (Balage, 1983) which show that radioactivity accumulates in kidneys during the first 10 min following injection, whereas it displays a decay curve in liver. Furthermore, during this period, the radioactivity associated with liver can be displaced in vivo by unlabelled glucagon, according to a time-related dose-response curve suggesting that a large part of injected !251-glucagon is bound specifically and reversibly to liver structures (e.g. plasma membrane receptors). This is in good agreement with previous observations from direct studies of radioactivity in subcellular fractions of liver (Desbuquois and Postel-Vinay, 1980 ; Barazzone et al., 1980) . 
